Anticipated Shortage

PMS-IRBESARTAN

PHARMASCIENCE INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PMS-IRBESARTAN in Canada?

A shortage of PMS-IRBESARTAN 300MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 4, 2026), but it has not started yet.

Why is PMS-IRBESARTAN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will PMS-IRBESARTAN be available again?

The manufacturer's estimated resolution date is March 11, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file6 products

Expected resolution~5 months remaining (estimate)

Affected strength300MG

Last updated2026-09-04

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

IRBESARTAN

ACTAVIS PHARMA COMPANY

300MG · DIN 02433842

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

IPG-IRBESARTAN

MARCAN PHARMACEUTICALS INC

300MG · DIN 02435454

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MAR-IRBESARTAN

MARCAN PHARMACEUTICALS INC

300MG · DIN 02436124

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

AVAPRO

SANOFI-AVENTIS CANADA INC

150MG · DIN 02237924

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

VAN-IRBESARTAN

VANC PHARMACEUTICALS INC

75MG · DIN 02427087

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

RIVA-IRBESARTAN

LABORATOIRE RIVA INC.

75MG · DIN 02425319

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2027-03-11

~5 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02317087

Strength

300MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

IRBESARTAN

Tier

Unrated

Last Updated

2026-09-04

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from PHARMASCIENCE INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AC&C TABLETS

DIN 02303299

ACET CODEINE 30

DIN 01999648

ACET CODEINE 60

DIN 01999656

ACETAMINOPHEN, CAFFEINE & CODEINE

DIN 02028174

ACETAMINOPHEN, CAFFEINE & CODEINE

DIN 02025337

ARTHRITIS PAIN RELIEF

650MG · DIN 02527901